Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01925781 · ClinicalTrials.gov registry record · Phase 4
e-Cigarettes Versus NRT Gum for Smoking Cessation
A Phase 4 study, sponsored by Creighton University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT01925781: Clinical Trial Phase 4 study, sponsored by Creighton University.
NCT01925781 is a Phase 4 study that was terminated before completion, run by Creighton University. The registered enrollment target is 10 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01925781, a Phase 4 study, was terminated before completion, sponsored by Creighton University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
This is a randomized trial comparing electronic cigarettes (e-Cigarettes) to nicotine gum for smoking cessation. Participants will be randomly assigned to either e-cigarette use or nicotine gum use during a quit attempt. All participants will have a one hour meeting with a tobacco treatment specialist to develop a quit plan and set a quit date. Quit status will be determined at 12 weeks after the quit date. Continued use of nicotine replacement (either e-Cigarette or nicotine gum) and satisfaction with the treatment assignment will be evaluated.
Primary Outcome
No smoking at 12 weeks after the predetermined quit date with a 5 day grace period. Self-report will be biochemically confirmed with expired carbon monoxide (CO) and salivary cotinine.
Interventions
- DRUG Nicotine polacrilex
- OTHER STAM 1100mAh CE4 eGo Clearomizer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-08 |
| Est. Completion | 2013-11 |
| Phase | Phase 4 |
Why NCT01925781 stopped before completion
NCT01925781 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Nicotine polacrilex is the first listed.
NCT01925781 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01925781 about?
NCT01925781 is a clinical study titled "e-Cigarettes Versus NRT Gum for Smoking Cessation". This is a randomized trial comparing electronic cigarettes (e-Cigarettes) to nicotine gum for smoking cessation. Participants will be randomly assigned to either e-cigarette use or nicotine gum use during a quit attempt. All participants will have a one hour meeting with a tobacco treatment speciali...
What is the current status of trial NCT01925781?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2013-08. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01925781?
The interventions under investigation include: Nicotine polacrilex (DRUG), STAM 1100mAh CE4 eGo Clearomizer (OTHER).
Who is sponsoring clinical trial NCT01925781?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01925781's enrollment target sits among peer trials
10 1940th of 2000 higher than 33 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia